Skip to main content
Equibles
BVS logo

BVS · Bioventus Inc. · Analyst Estimates

Track BVS — free

Use BVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.15 -0.18 (-1.31%) At close · Nov 2 Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$1.11B
Shares
84.26M
Volume · Nov 2 675.95K Avg daily vol (3M) 564.26K

Analyst Estimates

Compare analyst forecasts for Bioventus Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-29 23:36 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.77
0.78
0.79
5
0.78
0.78
0.78
0.78
1
1
0
0
Revenue
USD
Publication date not stated
602.01M
604.79M
606.00M
5
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.88
0.92
0.96
5
0.92
0.92
0.92
0.91
1
2
1
1
Revenue
USD
Publication date not stated
641.01M
645.57M
656.00M
5
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.13
0.16
0.18
5
0.16
0.16
0.16
0.18
2
3
0
0
Revenue
USD
Publication date not stated
148.36M
149.52M
150.70M
5
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.23
0.25
0.28
5
0.25
0.25
0.25
0.24
0
2
1
2
Revenue
USD
Publication date not stated
168.35M
169.96M
170.80M
5
 — — — — — — — —
Key facts CIK 1665988 CUSIP 09075A108 13F (30d) 31 filings 31 filers Visit website Investor relations